Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer?
Alessandra Murabito, Emilio Hirsch, Alessandra Ghigo
Frontiers in Cardiovascular Medicine (2020) Vol. 7
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Mitochondrial-Targeted Therapy for Doxorubicin-Induced Cardiotoxicity
Bin Bin Wu, Kam Tong Leung, Ellen Poon
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1912-1912
Open Access | Times Cited: 126
Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection
Marco Bruno Morelli, Chiara Bongiovanni, Silvia Da Pra, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 95
Anthracycline-induced cardiotoxicity — are we about to clear this hurdle?
Wolfram Dempke, Rafał Zieliński, C. Winkler, et al.
European Journal of Cancer (2023) Vol. 185, pp. 94-104
Open Access | Times Cited: 52
Anthracycline Cardiotoxicity in Adult Cancer Patients
Massimiliano Camilli, Carlo M. Cipolla, Susan Dent, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 5, pp. 655-677
Open Access | Times Cited: 21
Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy
Qiulan Zhang, Jingjie Yang, Hongsheng Zhang
Biomedicine & Pharmacotherapy (2018) Vol. 109, pp. 71-83
Open Access | Times Cited: 87
Understanding Anthracycline Cardiotoxicity From Mitochondrial Aspect
Junqi Huang, Rundong Wu, Linyi Chen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 57
Sex difference in human diseases: mechanistic insights and clinical implications
Yuncong Shi, Jianshuai Ma, Sijin Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Mitochondrial Dysfunction and Heart Disease: Critical Appraisal of an Overlooked Association
Giandomenico Bisaccia, Fabrizio Ricci, Sabina Gallina, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 614-614
Open Access | Times Cited: 53
Effects of anticancer drugs on the cardiac mitochondrial toxicity and their underlying mechanisms for novel cardiac protective strategies
Cho‐Won Kim, Kyung‐Chul Choi
Life Sciences (2021) Vol. 277, pp. 119607-119607
Closed Access | Times Cited: 41
Combination of Panax ginseng C. A. Mey and Febuxostat Boasted Cardioprotective Effects Against Doxorubicin-Induced Acute Cardiotoxicity in Rats
Hayder M. Al‐kuraishy, Hany Akeel Al-Hussaniy, Ali I. Al‐Gareeb, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 37
Cardio-Oncology: Mechanisms, Drug Combinations, and Reverse Cardio-Oncology
Zehua Liang, Yuquan He, Xin Hu
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10617-10617
Open Access | Times Cited: 33
Plant-Derived Bioactive Compounds in Colorectal Cancer: Insights from Combined Regimens with Conventional Chemotherapy to Overcome Drug-Resistance
Laura Ioana Gavrilaș, Daniel Cruceriu, Andrei Mocan, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1948-1948
Open Access | Times Cited: 30
Anthracycline Cardiotoxicity Induces Progressive Changes in Myocardial Metabolism and Mitochondrial Quality Control
Anabel Díaz-Guerra, Rocío Villena-Gutiérrez, Agustín Clemente‐Moragón, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 2, pp. 217-232
Open Access | Times Cited: 8
Management of Fluoropyrimidine-Induced Cardiac Adverse Outcomes Following Cancer Treatment
Mohsen Rajaeinejad, Peyvand Parhizkar Roudsari, Mehran Khoshfetrat, et al.
Cardiovascular Toxicology (2024) Vol. 24, Iss. 2, pp. 184-198
Closed Access | Times Cited: 7
Resveratrol as Chemosensitizer Agent: State of Art and Future Perspectives
Veronica Cocetta, Vincenzo Quagliariello, Francesco Fiorica, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 2049-2049
Open Access | Times Cited: 40
Cardiovascular toxic effects of antitumor agents: Pathogenetic mechanisms
Despoina Pantazi, Alexandros D. Tselepis
Thrombosis Research (2022) Vol. 213, pp. S95-S102
Closed Access | Times Cited: 23
The Beneficial Role of Physical Exercise on Anthracyclines Induced Cardiotoxicity in Breast Cancer Patients
Eliana Tranchita, Arianna Murri, Elisa Grazioli, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2288-2288
Open Access | Times Cited: 19
The beneficial role of exercise in preventing doxorubicin-induced cardiotoxicity
Samantha L. Gaytan, Ahmed Lawan, Jongwha Chang, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 11
Cardioprotection with nebivolol in patients undergoing anthracyclines: a randomized placebo-controlled trial
Giulio Stefanini, Carmelo Carlo‐Stella, F. Cannata, et al.
Cardiovascular Research (2025)
Closed Access
Investigation of chemotherapy-induced cardiac dysfunction in breast cancer
Sai Harini Chandrasekaran, Pugazhendi Inban, Reeju Maharjan, et al.
Journal of Chemotherapy (2025), pp. 1-11
Closed Access
Mitochondrial dysfunction in cardiovascular disease: investigating therapeutic approaches to enhance patient outcomes
Omar Elsaka
MGM Journal of Medical Sciences (2025) Vol. 12, Iss. 1, pp. 127-135
Open Access
Anthracycline Associated Disturbances of Cardiovascular Homeostasis
Ashot Avagimyan, L. V. Kakturskiy, Kiyan Heshmat‐Ghahdarijani, et al.
Current Problems in Cardiology (2021) Vol. 47, Iss. 5, pp. 100909-100909
Closed Access | Times Cited: 24
The Role of Mitochondrial Quality Control in Anthracycline-Induced Cardiotoxicity: From Bench to Bedside
Yukun Li, Rong Lin, Xiaodong Peng, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-22
Open Access | Times Cited: 17
Protection against cancer therapy-induced cardiovascular injury by planed-derived polyphenols and nanomaterials
Yunshu Liao, Qinghua Meng
Environmental Research (2023) Vol. 238, pp. 116896-116896
Closed Access | Times Cited: 10
Molecular Imaging Biomarkers in Cardiooncology: A View on Established Technologies and Future Perspectives
David Kersting, Ilektra-Antonia Mavroeidi, Stephan Settelmeier, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. Supplement 2, pp. 29S-38S
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top